Well Lead Medical Co., Ltd. (SHA:603309)
China · Delayed Price · Currency is CNY 10.67
+0.07 (0.66%)
Oct 28, 2026, 11:30 AM CST
Well Lead Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 272.31 | 253.96 | 287.64 | 302.87 | 393.02 | 604.58 |
Trading Asset Securities | 221.25 | 265.09 | 192.62 | 144.08 | 310.94 | 30.19 |
Cash & Short-Term Investments | 493.55 | 519.05 | 480.26 | 446.95 | 703.96 | 634.77 |
Cash Growth | 15.03% | 8.08% | 7.45% | -36.51% | 10.90% | 292.19% |
Accounts Receivable | 206.56 | 222.66 | 209.81 | 190.26 | 96.22 | 134.01 |
Other Receivables | 7.48 | 15.2 | 9.99 | 11.88 | 9.74 | 9.92 |
Receivables | 214.04 | 237.85 | 219.79 | 202.14 | 105.96 | 143.93 |
Inventory | 221.42 | 189.05 | 168.61 | 143.04 | 163.03 | 168.31 |
Prepaid Expenses | - | 0.62 | 0.09 | 0.1 | 7.71 | 0.06 |
Other Current Assets | 21.99 | 20.61 | 17.31 | 25.16 | 13.46 | 27.47 |
Total Current Assets | 951 | 967.19 | 886.06 | 817.39 | 994.11 | 974.54 |
Property, Plant & Equipment | 785.08 | 789.94 | 653.66 | 848.2 | 594.29 | 581.78 |
Long-Term Investments | 140.08 | 144.73 | 170.18 | 270.67 | 130.38 | 48.91 |
Goodwill | 145.58 | 145.58 | 292.53 | 292.53 | 292.53 | 292.53 |
Other Intangible Assets | 163.43 | 170.48 | 181.71 | 167.74 | 172.99 | 182.89 |
Long-Term Deferred Tax Assets | 3.1 | 3.52 | 7.47 | 13.49 | 12.84 | 7.51 |
Long-Term Deferred Charges | 32.45 | 26.24 | 22.15 | 24.99 | 20.55 | 6.74 |
Other Long-Term Assets | 598.37 | 612.75 | 626.91 | 170.26 | 165.9 | 37.45 |
Total Assets | 2,819 | 2,860 | 2,841 | 2,605 | 2,384 | 2,132 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 176.45 | 203.45 | 218.83 | 158.7 | 178.63 | 112.83 |
Accrued Expenses | 48.04 | 97.51 | 104.03 | 110.45 | 88.41 | 72.11 |
Short-Term Debt | 170.1 | 170.11 | 110.07 | 90.07 | 115.82 | 95.94 |
Current Portion of Long-Term Debt | 47.41 | 24.67 | 14.39 | 4.52 | 0.05 | 50.13 |
Current Portion of Leases | - | 8.93 | 5.28 | 5.65 | 7.1 | 6.48 |
Current Income Taxes Payable | 18.85 | 14.34 | 9.95 | 11.6 | 9.96 | 8.65 |
Current Unearned Revenue | 38.63 | 33.78 | 36.45 | 30.76 | 45.81 | 31.93 |
Other Current Liabilities | 34.81 | 84.86 | 32.78 | 29.44 | 31.61 | 48.48 |
Total Current Liabilities | 534.3 | 637.65 | 531.79 | 441.2 | 477.38 | 426.55 |
Long-Term Debt | 335.98 | 364.42 | 349.01 | 268.65 | 104.42 | 57.03 |
Long-Term Leases | 44.57 | 54.24 | 29.45 | 28.19 | 32.6 | 35.03 |
Long-Term Unearned Revenue | 18.92 | 19.45 | 16.1 | 18.81 | 18.54 | 16.7 |
Long-Term Deferred Tax Liabilities | 9.06 | 8.13 | 11.27 | 11.52 | 10.91 | 5.57 |
Total Liabilities | 976.77 | 1,084 | 937.61 | 768.37 | 643.85 | 540.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 291.87 | 291.87 | 292.87 | 293.16 | 293.32 | 293.42 |
Additional Paid-In Capital | 638.83 | 638.83 | 644.82 | 650.73 | 651.73 | 633.04 |
Retained Earnings | 896.18 | 833.11 | 960.12 | 904.87 | 812.04 | 685.05 |
Treasury Stock | - | - | -6.36 | -8.24 | -14.49 | -24.22 |
Comprehensive Income & Other | -0.75 | -2.12 | -6.47 | -23.43 | -18.73 | -8.82 |
Total Common Equity | 1,826 | 1,762 | 1,885 | 1,817 | 1,724 | 1,578 |
Minority Interest | 16.18 | 14.85 | 18.1 | 19.82 | 15.89 | 13.01 |
Shareholders' Equity | 1,842 | 1,777 | 1,903 | 1,837 | 1,740 | 1,591 |
Total Liabilities & Equity | 2,819 | 2,860 | 2,841 | 2,605 | 2,384 | 2,132 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 598.05 | 622.38 | 508.2 | 397.08 | 260 | 244.62 |
Net Cash (Debt) | -104.5 | -103.33 | -27.94 | 49.87 | 443.96 | 390.15 |
Net Cash Growth | - | - | - | -88.77% | 13.79% | 1309.49% |
Net Cash Per Share | -0.36 | -0.35 | -0.10 | 0.17 | 1.52 | 1.51 |
Filing Date Shares Outstanding | 289.61 | 291.87 | 292.87 | 293.16 | 293.32 | 293.42 |
Total Common Shares Outstanding | 289.61 | 291.87 | 292.87 | 293.16 | 293.32 | 293.42 |
Working Capital | 416.7 | 329.54 | 354.28 | 376.19 | 516.73 | 547.99 |
Book Value Per Share | 6.31 | 6.04 | 6.44 | 6.20 | 5.88 | 5.38 |
Tangible Book Value | 1,517 | 1,446 | 1,411 | 1,357 | 1,258 | 1,103 |
Tangible Book Value Per Share | 5.24 | 4.95 | 4.82 | 4.63 | 4.29 | 3.76 |
Buildings | - | 531.94 | 393.75 | 429.34 | 393.32 | 379.99 |
Machinery | - | 415.76 | 371.44 | 343.97 | 307.39 | 283.76 |
Construction In Progress | - | 91.98 | 128.62 | 326.75 | 108.23 | 90.14 |